|
Consolidated Statements of Changes in Shareholders' Equity (USD $)
|
Common Stock [Member]
|
Additional Paid-in Capital [Member]
|
Retained Earnings [Member]
|
Accumulated Other Comprehensive Income (Loss) [Member]
|
Total
|
| Balance at Oct. 03, 2009 |
|
$ 792,466 |
$ 619,460 |
$ 19,161,414 |
|
$ 20,573,340 |
| Balance, Shares (in Shares) at Oct. 03, 2009 |
|
2,712,310 |
|
|
|
|
| Net income for the fiscal year |
|
|
|
4,506,215 |
|
4,506,215 |
| Common stock issued to Directors |
|
136,085 |
|
|
|
136,085 |
| Common stock issued to Directors, Shares (in Shares) |
|
8,500 |
|
|
|
|
| Common stock issued on exercise of stock options |
|
288,629 |
|
|
|
288,629 |
| Common stock issued on exercise of stock options, shares (in Shares) |
|
58,130 |
|
|
|
|
| Stock repurchase |
|
(346,234) |
|
|
|
(346,234) |
| Stock repurchase, shares (in Shares) |
|
(21,476) |
|
|
|
|
| Stock option compensation expense |
|
|
18,936 |
|
|
18,936 |
| Tax benefits for stock options exercised |
|
|
58,095 |
|
|
58,095 |
| Cash dividends paid or declared (per share) |
[1] |
|
|
(3,856,477) |
|
(3,856,477) |
| Balance at Oct. 02, 2010 |
|
870,946 |
696,491 |
19,811,152 |
|
21,378,589 |
| Balance, Shares (in Shares) at Oct. 02, 2010 |
|
2,757,464 |
|
|
|
|
| Net income for the fiscal year |
|
|
|
3,699,066 |
|
3,699,066 |
| Common stock issued to Directors |
|
128,945 |
|
|
|
128,945 |
| Common stock issued to Directors, Shares (in Shares) |
|
8,500 |
|
|
|
|
| Common stock issued on exercise of stock options |
|
120,107 |
|
|
|
120,107 |
| Common stock issued on exercise of stock options, shares (in Shares) |
|
29,145 |
|
|
|
|
| Stock repurchase |
|
(8,292) |
|
|
|
(8,292) |
| Stock repurchase, shares (in Shares) |
|
(600) |
|
|
|
|
| Stock option compensation expense |
|
|
69,497 |
|
|
69,497 |
| Cash dividends paid or declared (per share) |
|
|
|
(1,166,789) |
|
(1,166,789) |
| Balance at Oct. 01, 2011 |
|
1,111,706 |
765,988 |
22,343,429 |
|
24,221,123 |
| Balance, Shares (in Shares) at Oct. 01, 2011 |
|
2,794,509 |
|
|
|
2,794,509 |
| Net income for the fiscal year |
|
|
|
5,214,973 |
|
5,214,973 |
| Foreign currency translation gain |
|
|
|
|
284,396 |
284,396 |
| Common stock issued for acquisition of M.C. Healthcare Products Inc. |
|
1,441,000 |
|
|
|
1,441,000 |
| Common stock issued for acquisition of M.C. Healthcare Products Inc. (in Shares) |
|
100,000 |
|
|
|
|
| Common stock issued to Directors |
|
130,390 |
|
|
|
130,390 |
| Common stock issued to Directors, Shares (in Shares) |
|
8,500 |
|
|
|
|
| Common stock issued on exercise of stock options |
|
74,263 |
|
|
|
74,263 |
| Common stock issued on exercise of stock options, shares (in Shares) |
|
16,241 |
|
|
|
|
| Stock option compensation expense |
|
|
72,264 |
|
|
72,264 |
| Cash dividends paid or declared (per share) |
|
|
|
(1,358,425) |
|
(1,358,425) |
| Balance at Sep. 29, 2012 |
|
$ 2,757,359 |
$ 838,252 |
$ 26,199,977 |
$ 284,396 |
$ 30,079,984 |
| Balance, Shares (in Shares) at Sep. 29, 2012 |
|
2,919,250 |
|
|
|
2,919,250 |
|
|
|